Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 614 results found. Search for [ coronavirus vaccine developed in India ]

Results 140 to 160 of 614
BusinessToday.In
December 8, 2020
'If people are going to study one country right now, other than China, I'd say they should look at India,' Bill Gates said at the Singapore Fintech Festival


Reuters
December 8, 2020
Margaret Keenan, a 90-year-old grandmother from Britain, has become the first person in the world to receive the Pfizer COVID-19 vaccine outside of a trial following its rapid clinical approval


Rashi Bisaria
New Delhi, December 8, 2020
As promised, SII has applied for emergency use nod before 2020: Adar Poonawalla Adar Poonawalla, the head of vaccine-making company Serum Institute of India (SII), on Monday informed the company has applied for an emergency use authorisation for Covishield coronavirus vaccine to the Drugs Controller General of India (DCGI). Serum Institute, which is the world's largest vaccine producer by volume, has become the second company to apply for the emergency authorisation after Pfizer India. CO...


Joe C Mathew
December 7, 2020
Both companies have applied for vaccine approval, following which, these companies will be able to supply vaccines to the central government to begin its multi-phase vaccination of Indian residents against the COVID-19


BusinessToday.In
December 7, 2020
After American drug maker Pfizer and Pune-based Serum Institute, Bharat Biotech is the third company to apply for emergency use authorisation for its COVID-19 vaccine to the DCGI


BusinessToday.In
December 7, 2020
Pfizer's clarification comes as experts believe that storing the vaccine in minus 70 degree Celsius would be a big hurdle


BusinessToday.In
December 7, 2020
On December 2, the UK became the first nation to approve Pfizer-BioNTech vaccine against COVID-19 for emergency use; Bahrain has also approved vaccine candidate 'BNT162b2'. India decision on vaccine could come this week


BusinessToday.In
December 7, 2020
As per the Indian Council of Medical Research (ICMR), Serum Institute has manufactured four crore doses of the vaccine under the at-risk manufacturing and stockpiling licence obtained from the DCGI


BusinessToday.In
December 6, 2020
\"During this pandemic phase, Pfizer will supply this vaccine only via government contracts based on agreements with respective govt authorities & following regulatory authorization or approval\", the US pharma firm said


PTI
December 6, 2020
 Bharat Biotech said its vaccine is safe and efficacious  after Haryana Home Minister Anil Vij tested positive for the viral disease despite taking the first shot of the medication


BusinessToday.In
December 6, 2020
Pfizer Inc submitted application to DCGI seeking emergency use authorisation on Dec 4; also seeks permission to import vaccine for sale and distribution in India


BusinessToday.In
December 5, 2020
On December 2, the UK became the first country in the world to approve Pfizer and BioNTech coronavirus candidate BNT162b2 after the Medicines and Healthcare Products Regulatory Agency found the jab safe for widespread rollout


BusinessToday.In
December 5, 2020
The vaccine developer said on Saturday that the Covaxin clinical trials are based on a 2-dose routine, the two doses are administered 28 days apart and vaccine efficacy will be determined 14 days post the second dose


BusinessToday.In
December 5, 2020
DCGI VG Somani has said the CDSCO will facilitate analysis of interim clinical trial data at pre-defined stages. PM Modi says nearly eight vaccine candidates, out of which three are indigenously developed, are undergoing trials in India


BusinessToday.In
December 5, 2020
COVID-19 cases in India: The total number of coronavirus cases reached 96, 08,211, with over 36,000 cases reported in the last 24 hours


BusinessToday.In
December 4, 2020
COVID-19 vaccine trial updates: AIIMS director Dr Randeep Guleria has pinned his hopes on the five coronavirus vaccine candidates which are in varying stages of trials across India


BusinessToday.In
December 4, 2020
Study says anti-bodies declined slightly over time but remained elevated in all participants even 3 months after vaccination. NIAID director Anthony Fauci and other infectious diseases experts say it is possible that our bodies would remember virus and produce more anti-bodies if exposed to the virus again


BusinessToday.In
December 3, 2020
However, VK Paul, who heads the National Task Force on COVID-19, had said in November that the arrival of the Pfizer vaccine in India might take months.


BusinessToday.In
December 2, 2020
The decision comes as Russia recorded 589 new deaths on a day; Russian Deputy Prime Minister Tatiana Golikova that large-scale vaccinations on voluntary basis will began across the country soon


BusinessToday.In
December 2, 2020
The US-China Economic and Security Review Commission has told the US Congress that several weeks prior to the clash, Chinese Defence Minister Wei made his statement encouraging China to 'use fighting to promote stability'


PAGES 8 OF 31  678910